GW Pharmaceuticals PLC | Cash Flow
Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
7,101.20
24,350.20
68,721.90
90,003.40
166,810.60
340,416.30
Depreciation, Depletion & Amortization
1,543.90
2,322.20
3,550.00
5,184.70
6,993.50
11,708.80
Other Funds
-
12,993.20
-
-
-
66,205.10
Funds from Operations
10,164.00
26,611.00
80,985.00
125,373.00
140,940.50
262,502.40
Changes in Working Capital
1,333.10
5,777.30
9,570.50
6,283.30
1,884.90
34,367.80
Net Operating Cash Flow
11,497.10
20,833.60
71,414.50
119,089.70
139,055.70
296,870.10
Capital Expenditures
3,501.40
12,049.70
27,803.10
12,993.60
21,147.70
Sale of Fixed Assets & Businesses
-
23.30
3.10
-
-
Net Investing Cash Flow
3,501.40
12,026.40
27,800.00
12,993.60
21,147.70
Issuance/Reduction of Debt, Net
334.10
166.10
393.20
518.90
1,330.00
Net Financing Cash Flow
28,593.80
239,744.70
198,152.90
292,497.80
1,378.20
Net Change in Cash
13,634.20
210,000.80
108,536.70
197,264.50
168,747.40
Free Cash Flow
14,998.60
32,883.30
99,041.80
131,359.40
159,397.80
Change in Capital Stock
28,259.70
226,917.60
198,546.20
293,016.70
48.10
Exchange Rate Effect
39.00
3,116.20
9,598.20
36,850.00
7,165.80
About GW Pharmaceuticals
View Profile
